The marketing research of medicines used in ophthalmological practice of Ukraine
Keywords:medicines for use in ophthalmology, pharmaceutical market, market analysis, market share, price categories.
Aim. To analyze the domestic pharmaceutical market of medicines for the treatment of ophthalmic diseases taking into account their dosage forms.
Materials and methods. The analysis was carried out based on the data of the State Register of Medicinal Products of Ukraine, electronic databases, “Morion” information retrieval program and price lists of the weekly journal “Apteka” as of April 10, 2017. The work was based on the logical, system-analytical, statistical and comparative methods of analysis.
Results. A market share of domestic medicines was determined according their dosage forms; it was 40 % of the registered medicines among the total number of 227 trade names. The domestic producers with the largest range of medicines are PJSC “Farmak”, Kyiv (38 % of the registered medicines) and LLC “Experimental Plant of the SSCC”, Kharkiv (21 %). Distribution of the range of medicines of group S01X A “Other ophthalmologicals” was carried out into price categories, and their lower, middle and high prices were determined. With the application of the pricing method for the medicine developed with the focus on the prices of competitors it has been found that the most favorable position is in the middle price category.Conclusions. The results of the marketing research can be used when developing practical measures to increase the effectiveness of implementing socially adapted mechanisms for reimbursing the cost of ophthalmic drugs within the government measures to increase the availability of pharmaceutical care to patients in Ukraine.
Medvedovs’ka, N. V. (2013). Semeinaia meditsyna, 3 (47), 107–108.
Andriukova, L. M., Pіven’, O. P., Fetіsova, O. G., Kovalenko, S. M. (2011). Upravlinnia, ekonomika ta zabezpechennia yakosti v farmatsii, 6 (20), 79–84.
Tichonov, A. I., Jarnych, T. G., Czernych, W. P. et al. (2005). Teoria i praktyka wytwarzania leczniczych preparatow propolisowych. Khrakov: Marka, 274.
Tikhonov, A. I., Tikhonova, S. A., Yarnykh T. G., Shpychak, O. S. et al. (2010). Med natural’nii v meditsine i farmatsii (proishozhdenie, svoistva, primenenie, lekarstvennie preparati). Khrakov: Original, 263.
Shpychak, O. S. (2016). The theoretical and experimental substantiation of the composition and development of the technology of apiphytomedicines for use in sports medicine. Extended abstract of Doctor’s thesis. Khrakiv, 45.
Shpychak, O. S., Tikhonov, O. I., Zupanets, I. A., Shebeko, S. K. (2015). The experimental study of the anti–inflammatory properties of combined aerosols with the propolis phenolic hydrophobic drug. The Pharma Innovation, 3 (11), 26-29.
Shpychak, O. S., Tikhonov, O. I., Zupanets, I.A., Shebeko, S. K. (2015). The study of the analgesic properties of combined aerosols with the propolis phenolic hydrophobic drug in the experiment. The Pharma Innovation, 4 (3), 78–81.
Piven’, E. P., Andriukova, L. N. (2009). Farmakom, 1, 99–105.
Derzhavnii reestr lіkars’kyh zasobіv. On–line versіia. Retrieved from: http://www.moz.gov.ua/ua/portal/mtph_register_medicines/.
Kovalenko, V. N. (Ed.). (2017). Kompendium 2016 – Lekarstvennye preparaty. Kiev: MORION, 2270.
Dmitrik, E. (2017). Ezhenedel’nik Apteka, 2 (1073). Retrieved from: http://www.apteka.ua/article/398728.
Dmitrik, E. (2017). Ezhenedel’nik Apteka, 4 (1075). Retrieved from: http://www.apteka.ua/article/400102.
Yegorova G. B., Mitichkina T. S. (2011). RMZH “Klinicheskaia Oftal’mologiia”, 1, 23.
Zaval’ko І. V. (2013). Farmatsevtychnyi zhurnal, 1, 21–25.
Mnushko, Z. N., Pestun, I. V. (2008). Teoriia i praktika marketingovykh issledovanii v farmatsii.Kharkov: NFaU, 308.
Yudanov, A. Yu., Vol’skaia, E. A., Ishmuhametov, A. A., Denisova, M. N. (2007). Farmatsevticheskii marketing. Moscow: Remedium, 500.
Lekarstvennye sredstva. Baza dannyh OOO “Morion”. Retrieved from: www.morion.kiev.ua.
Copyright (c) 2017 National University of Pharmacy
This work is licensed under a Creative Commons Attribution 4.0 International License.Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).